Page last updated: 2024-11-05

urapidil and Lung Diseases, Obstructive

urapidil has been researched along with Lung Diseases, Obstructive in 6 studies

Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.

Research Excerpts

ExcerptRelevanceReference
"Urapidil is known to be an alpha 1-adrenoceptor antagonist and an agonist of central 5HT1A-receptors, and should be considered as a vasodilator."5.29Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil. ( Adnot, S; Samoyeau, R; Weitzenblum, E, 1995)
"Urapidil is known to be an alpha 1-adrenoceptor antagonist and an agonist of central 5HT1A-receptors, and should be considered as a vasodilator."1.29Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil. ( Adnot, S; Samoyeau, R; Weitzenblum, E, 1995)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's4 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wiessmann, KJ1
Münninghoff, J1
Krüger, C1
Späh, F1
Kottman, R1
Schmidt, U1
Adnot, S2
Samoyeau, R1
Weitzenblum, E1
Lewczuk, J1
Wrabec, K1
Cazzola, M1
Spinazzi, A1
Santangelo, G1
Steinijans, VW1
Wurst, W1
Solleder, P1
Girbino, G1
Andrivet, P1
Piquet, J1
Brun-Buisson, C1
Rauss, A1
Bignon, J1
Lemaire, F1

Reviews

1 review available for urapidil and Lung Diseases, Obstructive

ArticleYear
[Value of vasodilator agents in the treatment of diseases with pulmonary hypertension caused by chronic obstructive lung diseases].
    Pneumonologia i alergologia polska, 1991, Volume: 59, Issue:3-4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel B

1991

Trials

3 trials available for urapidil and Lung Diseases, Obstructive

ArticleYear
Effects of single intravenous administration of urapidil and diltiazem in patients with nonfixed pulmonary hypertension secondary to chronic obstructive lung disease.
    Journal of cardiovascular pharmacology, 1994, Volume: 23, Issue:4

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Diltiazem; Femal

1994
Acute effects of urapidil on airway response in hypertensive patients with chronic obstructive pulmonary disease.
    Drugs, 1990, Volume: 40 Suppl 4

    Topics: Adult; Aged; Antihypertensive Agents; Female; Forced Expiratory Volume; Humans; Hypertension; Lung D

1990
The effects of urapidil therapy on hemodynamics and gas exchange in exercising patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    The American review of respiratory disease, 1988, Volume: 137, Issue:5

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Carbon Dioxide; Clinical Trials as Topic; Forced Expi

1988

Other Studies

2 other studies available for urapidil and Lung Diseases, Obstructive

ArticleYear
[Antihypertensive therapy using urapidil in patients with obstructive lung diseases].
    Fortschritte der Medizin, 1983, Feb-17, Volume: 101, Issue:7

    Topics: Adult; Aged; Antihypertensive Agents; Blood Gas Analysis; Drug Evaluation; Female; Hemodynamics; Hum

1983
Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Blood pressure. Supplement, 1995, Volume: 3

    Topics: Antihypertensive Agents; Blood Pressure; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive

1995